European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Heat shock protein 60 as a novel therapeutic target for diabetes and rheumatoid arthritis (HSPFORTHERAPY)

Objective

Heat shock proteins are antigens of immune responses in autoimmunity. In experimental models they suppress inflammation and in clinical trials in diabetes and arthritis hsp60 has a proven therapeutic potential. We propose to analyse the underlying mechanisms by monitoring immunity to hsp60 in the models, in patients and during hsp60 peptide trials, with respect to both the adaptive and the innate part of the immune system.

Call for proposal

Data not available

Coordinator

UTRECHT UNIVERSITY
EU contribution
No data
Address
Yalelaan 1
3584 CL UTRECHT
Netherlands

See on map

Total cost
No data

Participants (5)